Biden Announces Enough COVID Vaccine For All Adult Americans By End Of May

BURLINGTON, IA - AUGUST 07: Former Vice President Joe Biden delivers remarks about White Nationalism during a campaign press conference on August 7, 2019 in Burlington, Iowa. (Photo by Tom Brenner/Getty Images)
BURLINGTON, IA - AUGUST 07: Democratic presidential candidate and former U.S. Vice President Joe Biden delivers remarks about White Nationalism during a campaign press conference on August 7, 2019 in Burlington, Iowa... BURLINGTON, IA - AUGUST 07: Democratic presidential candidate and former U.S. Vice President Joe Biden delivers remarks about White Nationalism during a campaign press conference on August 7, 2019 in Burlington, Iowa. (Photo by Tom Brenner/Getty Images) MORE LESS
|
March 2, 2021 4:52 p.m.
EDITORS' NOTE: TPM is making our COVID-19 coverage free to all readers during this national health crisis. If you’d like to support TPM's reporters, editors and staff, the best way to do so is to become a member.

The U.S. has secured enough doses of COVID-19 vaccine to inoculate the country’s adult population by the end of May, President Joe Biden said on Tuesday.

The announcement means that the country will achieve the mark of enough doses for all adult Americans two months earlier than previously planned. Biden said last month that there would be enough for all Americans by the end of July, while forecasts at the start of his presidency initially suggested that the country would reach the milestone at the end of August.

“We’re now on track to have enough vaccine supply for every adult in America by the end of May,” Biden said in remarks from the White House.

The President added that the Trump administration had failed to secure enough doses of FDA-authorized vaccines to cover the country’s population at all. The Trump administration passed up an opportunity from pharmaceutical giant Pfizer to order millions of additional doses.

At the time, it was unclear whether any inoculations beyond the two-shot Pfizer and Moderna mRNA vaccine would work.

“The prior administration had contacted for not nearly enough vaccine to cover all the adults in America,” Biden said. “We rectified that.”

The U.S. is now on track to have far more vaccine than would be necessary to inoculate every American, after the FDA issued emergency use authorization for the Johnson & Johnson vaccine on Saturday.

The Biden administration has flexed federal muscles in both the manufacturing and deployment of the shots, including a program announced on Tuesday that will see Merck produce COVID-19 vaccines created by its competitor J&J.

Key Coronavirus Crisis Links

TPM’s COVID-19 hub.
Josh Marshall’s Twitter List of Trusted Experts (Epidemiologists, Researchers, Clinicians, Journalists, Government Agencies) providing reliable real-time information on the COVID-19 Crisis.
COVID-19 Tracking Project (updated data on testing and infections in the U.S.).
Johns Hopkins Global COVID-19 Survey (most up to date numbers globally and for countries around the world).
Worldometers.info (extensive source of information and data visualizations on COVID-19 Crisis — discussion of data here).
Latest News
Change to Commenting Permissions Starting May 1st

Beginning May 1, 2021, the option to comment on an article will be reserved only for TPM members. Non-members and those with free accounts will still be able to read comments both past and present, but will no longer be able to participate.

We hope that dedicated participants in the comments will join us as members, and want to make it as easy as possible for you to to so. We are offering 40% OFF an annual Prime membership to TPM readers with commenting accounts.

40% Off an Annual Prime Membership

We also offer FREE memberships to those experiencing financial hardship and FREE memberships for students.

View all options
Comments
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: